首页> 外文期刊>Pharmacological research: The official journal of The Italian Pharmacological Society >Bisoprolol and hydrochlorothiazide effects on cardiovascular remodeling in spontaneously hypertensive rats.
【24h】

Bisoprolol and hydrochlorothiazide effects on cardiovascular remodeling in spontaneously hypertensive rats.

机译:比索洛尔和氢氯噻嗪对自发性高血压大鼠心血管重构的影响。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Anti-hypertensive agents may differently stimulate compensatory neuro-hormonal mechanisms and induce different effects on the cardiovascular remodeling and function. The combination of low doses of the two synergistic drugs may lead to a lesser activation of counter regulatory mechanisms and could provide optimal therapeutic benefit. We evaluated on spontaneously hypertensive rats the effect of 3-week period of anti-hypertensive treatment. Rats were divided into four groups: control, bisoprolol (100 mg kg-1), hydrochlorothiazide (10 mg kg-1), and their combination with low doses (10 and 1 mg kg-1, respectively). The effects of treatment were evaluated on neuro-hormonal stimulation, cardiac and vascular structure and function. The combination had synergistic anti-hypertensive effects and significantly reduced heart rate and blood pressure but to a lower extent compared with bisoprolol 100 mg kg-1. Combination therapy was associated with a lower renin activation compared to hydrochlorothiazide alone and improved endothelial function. Cardiovascular remodeling differed between the groups: with bisoprolol, cardiac hypertrophy was reduced; with the combination therapy, the aortic media/lumen ratio was most increased. The consequent shear stress reduction may explain the associated endothelial function improvement. Such favourable cardiovascular remodeling with diuretic-beta-blockade combination may participate to the long-term cardiovascular protection during anti-hypertensive treatment.
机译:抗高血压药可能会不同地刺激代偿性神经激素机制,并对心血管重构和功能产生不同的影响。低剂量两种协同药物的组合可能导致较少的反调节机制激活,并可能提供最佳的治疗效果。我们评估了自发性高血压大鼠3周期抗高血压治疗的效果。大鼠分为四组:对照组,比索洛尔(100 mg kg-1),氢氯噻嗪(10 mg kg-1)以及低剂量组合(分别为10和1 mg kg-1)。评价了对神经激素刺激,心脏和血管结构与功能的治疗效果。与比索洛尔100 mg kg-1相比,该组合具有协同的抗高血压作用,并显着降低了心率和血压,但程度较低。与单独使用氢氯噻嗪相比,联合治疗与较低的肾素活化有关,并改善了内皮功能。两组之间的心血管重塑有所不同:使用比索洛尔可减轻心脏肥大;联合治疗时,主动脉介质/管腔比增加最多。随之而来的剪切应力的降低可以解释相关的内皮功能的改善。利尿剂-β-受体阻滞剂组合的这种有利的心血管重塑可能参与抗高血压治疗期间的长期心血管保护。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号